Computational Studies of the Molecular Mechanisms Responsible for Ca2+ Permeation and Mg2+ Block of NMDA Receptors  by Veras, Lea et al.
612a Wednesday, February 29, 2012the entire LBD or the whole protein. Hence, b-TF1 is viewed as a suppressor of
InsP3 binding. Additional studies suggest that b-TF1 not only helps stabilize
LBD but also couples its conformational changes to the gate of the ion pore.
The crystal structures of b-TF1 alone and of b-TF2 plus ARF bound with
InsP3 have been solved separately. The latter structure reveals how InsP3 is co-
ordinated by various side-chains in the binding sites at the ARF - b-TF2 inter-
face, and mutation of these side-chains weakens InsP3 binding. Despite this
progress, the fundamental question of how InsP3 biases the gating conformation
of LBD remains. To address this question, we have determined the crystal
structure of the entire LBD of rat InsP3R1 in both InsP3-bound and -unbound
conformations, revealing a triangular architecture. Comparison of the InsP3-
bound and -unbound conformations strongly implies that b-TF1 and ARF
move as a rigid unit with respect to b-TF2. While LBD without InsP3-bound
may spontaneously transition between gating states, binding of InsP3 between
b-TF2 and ARF locks it in a state that would strongly bias the gating equilib-
rium toward the open state of the ion pore.
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A wealth of high-resolution structural information regarding pentameric
ligand-gated ion channels is now available, but less is known of the molecular
details underlying complex allosteric mechanisms involved in channel gating
and desensitization. Receptor allostery can be studied by identifying state-
dependent distance constraints that may be used in molecular modeling of these
receptors. Systematically generated single Cys mutations of the human a1 gly-
cine receptor (GlyR) expressed in insect cells were labeled with a clickable
methanethiosulfonate-benzophenone crosslinker. After covalent ligation to
Cys, crosslinks may then be introduced in the resting, open, or desensitized
states by photoactivation. Including an alkyne tag on the crosslinker permits
click chemistry addition of biotin, which allows for enrichment by avidin
chromatography. Mass spectrometry (MS) fingerprinting of monomeric and
higher-order GlyR bands on SDS-PAGE using ESI-QTOF MS/MS then allows
for determination of the site of crosslinking. Our initial proof-of-principle
studies conducted on purified GlyR have provided state-dependent information
on this receptor. This approach may be broadly applicable to studies of any
allosteric complex.
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Cyclic nucleotide-gated (CNG) channels and hyperpolarization-activated, cy-
clic nucleotide-modulated (HCN) channels are opened by the direct binding
of cyclic nucleotides (e.g. adenosine 3’,5’-cyclic monophosphate, cAMP).
The ligand binding domain is primarily formed by an eight-stranded b-roll
followed by two helices (B and C helices). Following agonist binding to res-
idues in the b-roll, the C helix is thought to initiate the opening conforma-
tional change by moving towards the binding pocket and transitioning from
a less ordered coil to a stable helix. To further investigate this hypothesis,
we expressed the soluble C-terminal domain of the HCN2 channel, which
contains the cyclic nucleotide binding domain, and introduced cysteines
into the C helix, which were labeled with the fluorophore bimane. Into the
same helix, we placed pairs of histidines in helical register. Colored transition
metal ions can bind to these histidines and quench the fluorophore by a FRET
mechanism. The amount of quenching was used to estimate the distance be-
tween the fluorophore and the metal binding site in the presence and absence
of cAMP. For all of the constructs tested, cAMP binding induced a large in-
crease in metal affinity at the di-histidine binding sites, indicating a stabiliza-
tion of the helical structure. We also observed a change in the total amount of
quenching in some constructs indicating a change in distance between the flu-
orophore and metal binding site. These data suggest a conformational change
within the C helix induced by ligand binding. When a similar di-histidine
binding site was introduced into the C helix of intact CNG channels, binding
of Ni2þ increased the efficacy of the partial agonist inosine 3’,5’-cyclic
monophosphate (cIMP), consistent with the hypothesis that stabilization of
the secondary structure of the C helix is part of the gating conformational
change.3111-Plat
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Acidic fluctuations occur within the brain and contribute to multiple physi-
ological and patho-physiological processes. Neurons possess specific mole-
cules to sense and respond to these pH changes. In particular, many
neurons express the acid sensing ion channels (ASICs). ASICs are ligand-
gated ion channels activated by extracellular protons. ASICs are permeable
to cations and depolarize neurons to mediate acid-dependent neuronal signal-
ing. Some ASIC channels are also permeable to calcium and these channels
are thought to play a particularly important role in neuronal processes. Spe-
cifically, ASIC1a subunits form channels permeable to calcium and contrib-
ute to multiple behaviors, seizure termination, pain, as well as neuronal
death initiated by prolonged acidosis following inflammation and stroke.
ASIC1a undergoes a process called steady-state desensitization in which
slow, incremental acidification causes the channels to desensitize rather
than undergo robust activation. Induction of steady-state desensitization pre-
vents ASIC1a-mediated neuronal death. Yet, specific neuropeptides present
within the brain limit steady-state desensitization and allow ASIC1a to acti-
vate following slow, incremental acidification. Two types of neuropeptides,
the RFamides and dynorphin-related peptides, interact directly with the ex-
tracellular domain of ASICs to modulate channel gating. In this work, we
explore the mechanism and protein domains responsible for modulation of
ASC1a steady-state desensitization by endogenous neuropeptides. We deter-
mined that (1) RFamide and dynorphins alter ASIC gating in distinct, but
overlapping ways; (2) dynorphins can compete with the inhibitory spider
toxin venom peptide PcTx1 for interaction with the channels; and (3) the ad-
dition of RFamide and dynorphins synergizes ASIC1a modulation. We also
present evidence that specific protein domains are involved in endogenous
neuropeptide modulation of ASIC1a. Together, these studies further define
endogenous neuropeptides as important modulators of ASIC1a activity and
present data indicating that distinct protein domains control neuropeptide
effects.
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The ionotropic glutamate receptors (iGluR) mediate the majority of the rapid
signalling at excitatory synapses in the brain. The binding of glutamate and
other agonist molecules to the ligand-binding domains (LBDs) of the iGluR
provides the free energy for driving intra-LBD conformational transitions
that open the gate of the ion channel. However, much less information is
available about inter-LBD motions. We recently showed that disulfide cross-
links between kainate receptor LBD dimers inhibit receptor activation (Das et
al, 2010, PNAS). Here, we used a combination of structural studies and elec-
trophysiology to map the conformational transitions of the LBD dimers be-
tween different states of the GluA2 receptor. Interdimer disulfide trapping
with exquisite functional sensitivity shows that the two subunit dimers must
translate relative to each other during activation, with the center of the dimers
moving towards the overall axis of the channel. The crosslink captures an in-
termediate state between resting and fully activated and has geometry (includ-
ing reduced linker separation) that provides new insight to glutamate receptor
activation.
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Ca2D Permeation and Mg2D Block of NMDA Receptors
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Glutamate receptors are membrane proteins activated by the neurotransmitter
glutamate that mediate fast synaptic excitation in the mammalian brain.
NMDA receptors constitute a glutamate receptor subfamily specifically
Wednesday, February 29, 2012 613aactivated by N-methyl-d-aspartate. Due to their high Ca2þ permeability and
voltage-dependent channel block by Mg2þ, NMDA receptors play a central
role in development through stabilization of synaptic connections, as well as
in learning and memory by mediating many forms of synaptic plasticity.
The mechanisms by which the ion channel of NMDA receptors selects Ca2þ
for permeation over all other physiological ions, while binding Mg2þ and
restricting its permeation, are not well understood. We hypothesize that the
slightly different radii and electronic properties of Mg2þ and Ca2þ ions result
in drastically different free energy barriers for transition of the ions from
a binding site in the selectivity filter toward the intracellular solution. We
are applying quantitative theoretical ‘‘bottom up’’ approaches to this complex
system by combining methods of computational chemistry, molecular mechan-
ics (MM), and bioinformatics. The structure of the NMDA receptor channel is
constructed and refined using experimental information, homology modeling
and extensive molecular dynamics simulations. We are performing quantum
chemical calculations to determine the energy of the transition state of model
ligand exchange reactions that mimic divalent ion transition from the selectiv-
ity filter of NMDA receptors to water. Quantum calculations are used to
parameterize a polarizable molecular mechanics force field for these divalent
ion interactions with organic ligands with the further goal to perform MM sim-
ulations. Umbrella sampling and thermodynamic integration simulations are
used to compute free energies of transfer of divalent ions between water
and a model of the NMDA ion selectivity filter as well as free energy barriers
for these transitions.
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The ionotropic glutamate receptors (iGluRs), activated by the amino acid
L-glutamate, account for the vast majority of excitatory neurotransmission in
the central nervous system. Given their centrality to the nervous system, it is
not surprising that these receptors have been linked to various neurological
disorders including epilepsy, Alzheimer’s and Parkinson’s disease. Based on
their sequence, pharmacological properties and function, iGluRs are classified
primarily into three subtypes, namely amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA), kainate (KA), and N-methyl-D-aspartate
(NMDA) receptors.
Previously we have reported the identification of a potential ionic switch, or
latch, located within the hinge region of non-NMDA receptors. Here we de-
scribe extensive molecular dynamics simulations to explore the conformational
behaviour of the ionic switch and its influence on the closure or opening of the
ligand-binding domain. The position of the switch appears to directly control
the conformation of the ligand-binding domain. We discuss the results with re-
spect to the general mechanism of how different ligands are able to induce the
same mechanism of domain closure.
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Kainate-type ionotropic glutamate receptors (KARs) assemble primarily as
heteromeric complexes at glutamatergic synapses. In most cases, KAR-
mediated synaptic events exhibit slow and variable deactivation kinetics in
contrast to the fast gating properties typically observed with recombinant
KARs. It is still not clear which factors contribute to the slowing of KAR re-
sponses at synapses, and it remains to be understood the low affinity neuro-
transmitter, L-Glu, triggers prolonged activations of KARs. Here, we
investigated the biophysical and stoichiometric properties of recombinant het-
eromeric KARs assembled from the GluK2 and GluK5 receptor subunits. To
do this, we used a combination of outside-out patch electrophysiology to ex-
amine functionality and a fluorescent subunit counting technique to assess het-
eromerization. As expected, the degree of heteromerization with GluK2/
GluK5 subunits in individual patch recordings showed a positive correlation
with slow deactivation kinetics and responsiveness to the agonist, AMPA. In-
terestingly, preliminary data from subunit counting experiments suggest that
the stoichiometry of heteromeric KARs is fixed. Furthermore, electrophysio-
logical experiments reveal that GluK2/GluK5 heteromers are insensitive to
external anions and cations. Since both anion and cation binding sites line
the interface between KARs subunits, our data suggest that the process ofheteromer assembly affects functionality by disrupting this region of the
mature protein.Platform: Cardiac Muscle
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Familial Hypertrophic Cardiomyopathy (FHC) is an autosomal dominant
disease of the heart. The severity of the disease ranges from mild cases to
sudden cardiac death or progression to heart failure. FHC is mostly caused
by mutations in genes encoding for sarcomeric proteins, 30-40% of the patients
are affected by missense mutations in one allele of the b-myosin heavy chain
(MYH7).
To gain further insights into the mechanisms of FHC-progression in heterozy-
gous patients we performed a comparative expression analysis of the wildtype
and the mutated MYH7 allele. We have analyzed samples from Musculus
soleus and myocardium of genotyped and clinically well-characterized
FHC-patients with different MYH7-mutations. We demonstrated an unequal
allelic mRNA expression for each mutation analysed. The ratios of the mu-
tated mRNA ranged from 29% to 66% in a mutation-specific manner. They
were comparable in myocardium and soleus muscle and, importantly, were es-
sentially the same at the protein level. Intriguingly, we observed a correlation
between life expectancy and fraction of mutated mRNA or protein. Thus, the
allelic imbalance may provide a novel factor underlying the progression of
FHC.
Our results suggest that the allelic imbalance is induced by differential regula-
tion of the mutated MYH7 mRNA-expression. Thus we aimed to identify
molecular mechanisms that may account for the mutation-related different
mRNA levels. Bioinformatical analysis revealed that mutation V606M disrupts
an exonic splicing enhancer site. Additionally, for the mutation R723G severe
changes in the mRNA secondary structure were predicted. Alternative splicing
variants of the V606-allele and a structure-related increased stability of
the R723G-allele thus may provide potential factors inducing altered levels
of mutated MYH7-mRNA.
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Hypertrophic cardiomyopathies (HCM) and dilated cardiomyopathies (DCM)
are common inherited cardiovascular diseases, often resulting from single
point mutations in genes encoding sarcomeric proteins. Genetic and clinical
studies have identified several hundred mutations, including severe disease
causing mutations in b-myosin heavy chain (MHC). Despite the clinical sig-
nificance, few single molecule studies exist for mutated b-cardiac myosin,
primarily due to difficulties of heterologous protein expression and instrumen-
tal limitations. Previous studies have used mouse a-cardiac myosin or biopsies
from patients. Those studies are not optimal to understand the molecular
mechanism of HCM/DCM because there are significant differences between
mouse a- and human b-MHC. Furthermore, biopsy samples from patients
are often inhomogeneous mixtures of wildtype (wt) and mutants. This may
explain why there have been many inconsistencies between the previous
studies.
Here, we demonstrate the first single molecule studies of recombinant human
cardiac myosin. We expressed homogenous and fully functional wt human
cardiac a- and b-S1 with human light chains bound. Then, we characterized
